Last Update Time:
13-Mar-2025 16:00:00
ISIN:
INE0GK401011
Sector:
Chemicals
Symbol:
TATVA
Tatva Chintan Pharma Chem Limited
₹637.00
₹-39.25
(-5.80%)
▼
Prev. Close
₹676.25
Open
₹672.20
Close
₹637.00
Range
₹605.15 - ₹668.85
High
₹684.00
Low
₹631.05
Ind. Close
₹0.00
VWAP
₹651.31
The current stock price of Tatva Chintan Pharma Chem Limited is ₹637.00, with a target price range between ₹605.15 and ₹668.85. The stock has experienced a price change of ₹-39.25 (-5.80%), reflecting recent market volatility.
Today's opening price was ₹672.20, while the previous close stood at ₹676.25.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Tatva Chintan Pharma Chem Limited Price Chart
Tatva Chintan Pharma Chem Limited Pre Open Market Overview: 13-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 672.2
- Previous Close Price: 676.25
- Change: -4.05%
- Total Traded Volume: 226
- Total Buy Quantity: 1,775
- Total Sell Quantity: 1,299
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 670.00 | 24.00 | 0.00 |
| 670.05 | 1.00 | 0.00 |
| 671.10 | 5.00 | 0.00 |
| 671.65 | 2.00 | 0.00 |
| 672.20 | 35.00 | 0.00 |
| 676.00 | 0.00 | 22.00 |
| 676.25 | 0.00 | 35.00 |
| 686.35 | 0.00 | 6.00 |
| 689.85 | 0.00 | 21.00 |
| 690.00 | 0.00 | 51.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 1775
Total Sell Quantity: 1299
Shareholding Patterns of Tatva Chintan Pharma Chem Limited
Key Trade Statistics of Tatva Chintan Pharma Chem Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.81 |
| Traded Value (₹ Cr.) | 5.31 |
| Total Market Cap (₹ Cr.) | 1,490.07 |
| Free Float Market Cap (₹ Cr.) | 416.92 |
| Impact cost | 0.17 |
| Quantity Traded | 81,485.00 |
| Deliverable Quantity | 44,334.00 |
| % of Quantity to Traded | 54.41 |
| Security VaR | 14.77 |
| Index VaR | N/A |
| VaR Margin | 14.77 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 18.27 |
| Face Value | 10 |
Key Price Statistics of Tatva Chintan Pharma Chem Limited
The 52-week high for Tatva Chintan Pharma Chem Limited was ₹1,320.00, recorded on 08-Apr-2024. On the other hand, the 52-week low stands at ₹631.05, with the lowest value recorded on 13-Mar-2025.
The upper band for trading is ₹811.50, and the lower band is ₹541.00. The price band is 20%.
The stock's daily volatility stands at 2.30, while the annualized volatility is 43.94. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (08-Apr-2024) | 1,320.00 |
| 52 Week Low (13-Mar-2025) | 631.05 |
| Upper Band | 811.50 |
| Lower Band | 541.00 |
| Price Band (%) | 20 |
| Daily Volatility | 2.30 |
| Annualised Volatility | 43.94 |
| Tick Size | 0.05 |
Key Securities Statistics of Tatva Chintan Pharma Chem Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 29-Jul-2021 |
| Adjusted P/E | 104.22 |
| Symbol P/E | 104.22 |
| Index | NA |
| Macro-Economic Sector | Commodities |
| Sector | Chemicals |
| Industry | Chemicals & Petrochemicals |
| Basic Industry | Specialty Chemicals |
Security Status of Tatva Chintan Pharma Chem Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Tatva Chintan Pharma Chem Limited
| Subject | Date |
|---|---|
| Analysts/Institutional Investor Meet/Con. Call Updates | 31-Jan-2025 |
| Copy of Newspaper Publication | 29-Jan-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 28-Jan-2025 |
| Integrated Filing- Financial | 28-Jan-2025 |
| Investor Presentation | 28-Jan-2025 |
| Outcome of Board Meeting | 28-Jan-2025 |
| Financial Result Updates | 28-Jan-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 17-Jan-2025 |
Corporate Actions of Tatva Chintan Pharma Chem Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Dividend - Rs 2 Per Share | 06-Sep-2024 |
| 10 | Annual General Meeting | 06-Sep-2024 |
| 10 | Dividend - Rs 2 Per Share | 08-Sep-2023 |
| 10 | Annual General Meeting | 08-Sep-2023 |
| 10 | Annual General Meeting | 08-Sep-2022 |
| 10 | Dividend - Rs 2 Per Share | 08-Sep-2022 |
| 10 | Annual General Meeting | 17-Sep-2021 |
Board Meetings of Tatva Chintan Pharma Chem Limited
Financial Results of Tatva Chintan Pharma Chem Limited
Company Directory of Tatva Chintan Pharma Chem Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| N/A | Head Office/ Corporate Office | Plot No. 353 GIDC Makarpura |
VADODARA |
| N/A | Registered Office | Plot No. 502/17, GIDC Estate |
ANKLESHWAR |
| N/A | Transfer Agent | C-101, 1st Floor 247 Park, Lal Bahadur Shastri Marg, Vikhroli (West) Mumbai |
MUMBAI |
Insider Trading of Tatva Chintan Pharma Chem Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Ajay Mansukhlal Patel (HUF) | 338876786 | Sell |
| 7(2) | Ajay Mansukhlal Patel | 11800288 | Sell |
| 7(2) | Darshana Nitinkumar Shah | 383283762 | Sell |
| 7(2) | Priti Ajay Patel | 33529588 | Sell |
| 7(2) | Shekhar Rasiklal Somani | 385208369 | Sell |
Annual Reports of Tatva Chintan Pharma Chem Limited
Investor Complaints of Tatva Chintan Pharma Chem Limited
Event Calendar of Tatva Chintan Pharma Chem Limited
| Purpose | Details |
|---|---|
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Financial results | Tatva Chintan Pharma Chem Limited has informed the Exchange about Board Meeting to be held on 25-Jul-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Tatva Chintan Pharma Chem Limited has informed the Exchange about Board Meeting to be held on 04-Nov-2022 to consider financial statements for the period ended September 2022 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2023 and dividend, if any. |
| Fund Raising/Other business matters | To consider Fund Raising and other business transactions, as applicable. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Other business matters | To consider other business matters |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and dividend, if any. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Tatva Chintan Pharma Chem Limited
| Company | Period | Reg.7 | Reg.40 |
|---|---|---|---|
| Tatva Chintan Pharma Chem Limited | 31-MAR-2024 | ||
| Tatva Chintan Pharma Chem Limited | 31-MAR-2023 | ||
| Tatva Chintan Pharma Chem Limited | 31-MAR-2022 |
Voting Results of Tatva Chintan Pharma Chem Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 20-SEP-2024 | AGM | To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended 31 March 2024, together with the Reports of the Board of Directors and the Auditors thereon. |
| 20-SEP-2024 | AGM | Ratification of remuneration payable to the Cost Auditors for the Financial Year 2024-25 |
| 20-SEP-2024 | AGM | To consider and approve managerial remuneration payable to Mr. Shekhar Rasiklal Somani (DIN: 00183665) being Wholetime Director of the Company for his remaining tenure. |
| 20-SEP-2024 | AGM | To consider and approve managerial remuneration payable to Mr. Ajaykumar Mansukhlal Patel (DIN: 00183745) being Wholetime Director of the Company for his remaining tenure. |
| 20-SEP-2024 | AGM | To consider and approve managerial remuneration payable to Mr. Chintan Nitinkumar Shah (DIN: 00183618) being Managing Director of the Company for his remaining tenure. |
| 20-SEP-2024 | AGM | To appoint a Director in place of Mr. Chintan Nitinkumar Shah (DIN: 00183618) who retires by rotation and being eligible, offers himself for re-appointment. |
| 20-SEP-2024 | AGM | To declare dividend on equity shares for the financial year ended 31 March 2024. |
| 20-SEP-2024 | AGM | To receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended 31 March 2024, together with the Report of the Auditors thereon. |
| 22-SEP-2023 | AGM | To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended 31 March 2023, together with the Reports of the Board of Directors and the Auditors thereon. |
| 22-SEP-2023 | AGM | Ratification of remuneration payable to the Cost Auditors for the Financial Year 2023-24. |
| 22-SEP-2023 | AGM | Re-appointment of Statutory Auditors of the Company. |
| 22-SEP-2023 | AGM | To appoint a Director in place of Mr. Shekhar Rasiklal Somani (DIN: 00183665) who retires by rotation and being eligible, offers himself for re-appointment. |
| 22-SEP-2023 | AGM | To declare dividend on equity shares for the financial year ended 31 March 2023. |
| 22-SEP-2023 | AGM | To receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended 31 March 2023, together with the Report of the Auditors thereon. |
| 13-AUG-2023 | Postal Ballot | To Consider and Approve Raising of the Funds through issuance of securities of the Company by way of Qualified Institutional Placement (QIP) and other Permissible Modes for an amount not exceeding Rs. 2,000 million. |
| 22-SEP-2022 | AGM | To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended 31 March 2022, together with the Reports of the Board of Directors and the Auditors thereon. |
| 22-SEP-2022 | AGM | Ratification of remuneration payable to the Cost Auditors for the Financial Year 2022-23. |
| 22-SEP-2022 | AGM | To appoint a Director in place of Mr. Ajaykumar Mansukhlal Patel (DIN: 00183745) who retires by rotation and being eligible, offers himself for re-appointment. |
| 22-SEP-2022 | AGM | To declare dividend on equity shares for the financial year ended 31 March 2022. |
| 22-SEP-2022 | AGM | To receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended 31 March 2022, together with the Report of the Auditors thereon. |
FAQs on Tatva Chintan Pharma Chem Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.